Sleep disorders affect over 2 billion people worldwide, with 1 billion suffering from obstructive sleep apnea, a condition linked to serious health issues such as hypertension, diabetes, and cardiovascular disease. Despite the prevalence, diagnosis and treatment remain cumbersome, costly, and often uncomfortable, leading to underdiagnosis and poor adherence.

Building on more than a decade of research, Sunrise has developed Sensa, a lightweight, wearable device that tracks mandibular movements to provide a 90-95% accurate sleep apnea diagnosis compared to polysomnography. Coupled with a proprietary machine learning algorithm, Sensa distinguishes normal sleep, snoring, arousals, and respiratory events with clinical validation in over 500 patients. This approach offers a simpler, more patient-friendly alternative to traditional polysomnography while maintaining precision and reliability.